2003, Número s1
<< Anterior Siguiente >>
Gac Med Mex 2003; 139 (s1)
Anticoncepción de emergencia
Larrea F, Durand CM, Cravioto MC, Schiavon R
Idioma: Español
Referencias bibliográficas: 39
Paginas: 29-36
Archivo PDF: 141.58 Kb.
RESUMEN
La anticoncepción de emergencia representa una excelente opción para la prevención de embarazos no deseados y de abortos inducidos. A este respecto, el aborto inseguro es responsable de la muerte de miles de mujeres en edad reproductiva, especialmente en países en vías de desarrollo, muchas de ellas prevenibles si se proporciona la información y acceso apropiados a este método para el control de la fertilidad. En esta revisión se discuten los métodos utilizados y sus mecanismos de acción con la finalidad de contribuir desde la perspectiva biomédica al mejor conocimiento, usos y beneficios de la anticoncepción de emergencia.
REFERENCIAS (EN ESTE ARTÍCULO)
Schiavon R, Jiménez CH. Anticoncepción de emergencia: ¿Por qué nadie me dijo que existía? Rev Endocrinol Nutr 1999;7:46-50.
Bellagio Conference on Emergency Contraception (editorial). Consensus statement on emergency contraception. Contraception 1995;52:211-213.
Parkes AS, Bellerby CW. Studies on the internal secretions of the ovary. II. The effects of injection of the oestrus producing hormone during pregnancy. J Physiol 1926;62:145-155.
Parkes AS, Dodds EC, Noble RL. Interruption of early pregnancy by means of orally active estrogens. Br Med J 1938;2:557-559.
Smith MG. On the interruption of pregnancy in the rat by the injection of ovarian follicular extract. Bull Johns Hopkins Hosp 1926;39:203-214.
Morris JM, Waganen G. Compounds interfering with ovum implantation and development. III. The role of estrogens. Am J Obstet Gynecol 1966;6:804-815.
Yuzpe AA, Thurlow HJ, Ramzy I, Leyshon JI. Post coital contraception: a pilot study. J Reprod Med 1974;13:53-61.
World Health Organization. Task Force on Postovulatory Methods of Fertility Regulation. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined contraceptives for emergency contraception. Lancet 1998;352:428-433.
Kovacs L, Seregely G, Szilagyi J. Investigation of the pregnancy preventive effect of postcoital d-norgestrel under special experimental conditions. Honvedorvos 1979;3-4:289-293.
Moggia A, Beauquis A, Ferrari F, Torrado ML, Alonso JL, Koremblit E, Mischler T. The use of progestogens as postcoital contraceptives. J Reprod Med 1974;13:58-61.
Ho PC, Kwan MSW. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod 1993;8:389-392.
Glasier A. Emergency postcoital contraception. N Engl J Med 1997;337:1058-1064.
Yuzpe AA, Lancee WJ. Ethinylestradiol and dl-norgestrel as a postcoital contraceptive. Fertil Steril 1977;28:932-936.
Yuzpe AA, Percival Smith R, Rademaker AW. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as a postcoital contraceptive agent. Fertil Steril 1982;37:508-513.
Wilcox AJ, Weinberg CR, Baird DD. Timing the sexual intercourse in relation to ovulation. N Engl J Med 1995;333:1517-1521.
Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992;327:1041-1044.
World Health Organization. Task Force on Postovulatory Methods of Fertility Regulation. A randomized controlled trial comparing three single doses of mifepristone in emergency contraception. Lancet 1999;353:697-702.
Fluker MR, Marshall CA, Monroe SE. Jaffe RBA. Variable ovarian response to gonadotrophin-releasing hormone antagonist-induced gonadotrophin deprivation during different phases of the menstrual cycle. J Clin Endocrinol Metab 1991;72:912-919.
Dubourdieu S, Charbonnel B, Massai ME, Marraoui J, Spitz I, Bouchard P. Suppression of corpus luteum function by the gonadotrophin-releasing hormone anatgonist: Nal-Glu effect of the dose and timing of human chorionic gonadotrophin administration. Fertil Steril 1991;56:440-445.
Lippes J, Malik T, Tatum HJ. The post coital copper T. Thirteenth Annual Meeting of the Association of Planned Parenthood Physicians. Book of Abstracts, April 17, 1975;8p.
Haspels AA. Emergency contraception: a review. Contraception 1994;50:101-108.
Van Look P, Von Hertzen H. Emergency contraception. Br Med Bull 1993;49:158-170.
Von Hertzen H, Van Look PFA. Research on new methods of emergency contraception. Int Fam Plann Perspec 1996;28:52-58.
Swahn ML, Westlund P, Johannisson E, Bygdeman. Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle. Acta Obstet Gynecol Scand 1996;75:738-744.
Ling WY, Wrixon W, Acorn T, Wilson E, Collins J. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception III. Effects of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis. Fertil Steril 1983;40:631-636.
Croxatto HB, Fuentealba B, Brache V, Salvatierra AM, Alvarez F, Massai R, Cochon L, Faundes A. Effects of Yuzpe regimen, given during the follicular phase, on ovarian function. Contraception 2002;65:121-128
Ling WY, Wrixon W, Zayid Y, Acorn T, Popat R, Wilson E. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception II. Effects of postovulatory administration on ovarian function and endometrium. Fertil Steril 1983;39:292-297.
Ling WY, Robichaud A, Zayid Y, Wrixon W, MacLeod SC. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. Fertil Steril 1979;32:297-302.
Kubba AA, White JO, Guillebaud J, Elder MG. The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinylestradiol combination or danazol. Fertil Steril 1986;45:512-516.
Raymond EG, Lovely LP, Chen-Mok M, Seppälä M, Kurman RJ, Lessey BA. Effect of the Yuzpe regimen of emergency contraception on markers of endometrial receptivity. Hum Reprod 2000;15:2351-2355.
Kesserü E, Garmendia F, Westphal N, Parada J. The hormonal and peripheral effects of d-norgestrel in postcoital contraception. Contraception 1974;10:411-424.
Ugocsai G, Resch B, Traub A, Sas M. Biological, microscopic and scanning electron microscopic investigations of the effects of postinor/d-norgestrel in rabbits. Contraception 1984;30:153-159.
Landgren BM, Johannisson E, Aedo AR, Kumar A, Yong-en S. The effects of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology. Contraception 1989;39:275-289.
Spona J, Matt K, Schneider WHF. Study on the action of d-norgestrel as a postcoital contraceptive agent. Contraception 1975;11:31-43.
Garmendia F, Kesserü E, Urdanivia E, Valencia M. Luteinizing hormone and progesterone in women under postcoital contraception with d-norgestrel. Fertil Steril 1976;27:1250-1255.
Durand M, Cravioto MC, Raymond EG, Durán-Sánchez O, Cruz-Hinojosa ML, Castell-Rodríguez A, Schiavon R, Larrea F. On the mechanism of action of short-term levonorgestrel administration in emergency contraception. Contraception 2001;64:227-234.
Wang JD, Jiie W, Jiie C, Ruhua X, Hong-y W, Gen-mel Q, Peng-di Z. Effects of emergency contraceptive mifepristone and levonorgestrel on the endometrium at the time of implantation. International Conference on Reproductive Health; Mumbai, India 1998. p. A83.
Hapangama D, Glasier AF, Baird DT. The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle. Contraception 2001;63:123-129.
Piaggio G, von Hertzen H, Grimes DA, Van Look PFA. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Lancet 1999;353:721.